Tufts University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1852-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.tufts.edu
Clinical Trials
234
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (192 trials with phase data)• Click on a phase to view related trials
Gut Mini-Pill Study
- Conditions
- Gut Microbiota
- First Posted Date
- 2025-10-23
- Last Posted Date
- 2025-10-23
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 30
- Registration Number
- NCT07220369
- Locations
- 🇺🇸
Jean Mayer Human Nutrition Research Center on Aging, Boston, Massachusetts, United States
Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults
- Conditions
- Systemic InflammationChronic StressMobility and Independence
- First Posted Date
- 2025-10-17
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 20
- Registration Number
- NCT07217951
- Locations
- 🇺🇸
Jean Mayer USDA Human Nutrition Research Center on Aging, Boston, Massachusetts, United States
Effective Interventions to Overcome Severe Gag Reflex
- Conditions
- Gagging
- Interventions
- Device: AcupunctureGenetic: Masking TapeDrug: Anesthetic spray
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 45
- Registration Number
- NCT07099131
- Locations
- 🇺🇸
Tufts University School of Dental Medicine, Boston, Massachusetts, United States
Culturally-adapted Mobile Health Intervention for Hypertension Care
- Conditions
- Hypertension
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 160
- Registration Number
- NCT06985199
- Locations
- 🇬🇭
National Cardiothoracic Center, Accra, Ghana
🇬🇭Cardiothoracic Center - Outpatient Department, Ho, Ghana
Community Pharmacy Produce Prescriptions
- Conditions
- Diabetes Mellitus Type 2Hypertension
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 610
- Registration Number
- NCT06920355
- Prev
- 1
- 2
- 3
- 4
- 5
- 44
- Next
News
Japanese Researchers Begin Human Trials for Revolutionary Tooth Regeneration Drug
Japanese scientists have initiated clinical trials for a groundbreaking drug that could enable humans to regrow missing or damaged teeth by targeting the USAG-1 protein.
Psilocybin Clinical Trial Targets Treatment-Resistant IBS in Groundbreaking Gastroenterology Study
Dr. Erin E. Mauney at Massachusetts General Hospital is conducting the first clinical trial examining psilocybin's effects on treatment-resistant irritable bowel syndrome (IBS).
AVMA Veterinary Clinical Trials Registry Highlights New Studies in Canine and Feline Oncology and Neurological Disorders
The AVMA Veterinary Clinical Trials Registry lists studies for animal health, connecting researchers with veterinarians and owners.
Biophytis Receives FDA Authorization for First-Ever Phase 3 Sarcopenia Trial
Biophytis has received FDA authorization to launch SARA-31, marking the first-ever Phase 3 clinical trial specifically designed to treat sarcopenia, an age-related muscle wasting condition.
Biophytis Receives Regulatory Approval to Launch First-Ever Phase 3 Trial for Sarcopenia Treatment
Biophytis has received positive regulatory opinion from Belgian authorities to conduct SARA-31, marking the first phase 3 study ever launched in sarcopenia, a condition affecting over 30 million patients worldwide.